Vanguard Group Inc Theravance Biopharma, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,051,689 shares of TBPH stock, worth $19.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,051,689

Previous 2,002,179 2.47%

Holding current value

$19.7 Million

Previous $17 Million 2.6%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.66 - $10.25 $379,246 - $507,477	49,510 Added 2.47%	2,051,689 $16.5 Million
Q2 2024 Aug 13, 2024	SELL	$8.29 - $9.92 $5.67 Million - $6.78 Million	-683,674 Reduced 25.45%	2,002,179 $17 Million
Q1 2024 May 10, 2024	SELL	$8.22 - $11.59 $6.6 Million - $9.31 Million	-803,409 Reduced 23.03%	2,685,853 $24.1 Million
Q4 2023 Feb 14, 2024	SELL	$8.58 - $11.4 $3 Million - $3.99 Million	-350,067 Reduced 9.12%	3,489,262 $39.2 Million
Q3 2023 Nov 14, 2023	SELL	$8.38 - $10.44 $3.18 Million - $3.96 Million	-379,627 Reduced 9.0%	3,839,329 $33.1 Million
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $14.3 Million - $16.8 Million	-1,407,770 Reduced 25.02%	4,218,956 $43.7 Million
Q1 2023 May 15, 2023	BUY	$9.87 - $11.44 $670,044 - $776,627	67,887 Added 1.22%	5,626,726 $61 Million
Q4 2022 Feb 10, 2023	SELL	$9.65 - $11.34 $4.32 Million - $5.07 Million	-447,294 Reduced 7.45%	5,558,839 $62.4 Million
Q3 2022 Nov 14, 2022	SELL	$8.39 - $10.22 $4.52 Million - $5.51 Million	-538,673 Reduced 8.23%	6,006,133 $60.9 Million
Q2 2022 Aug 12, 2022	SELL	$8.41 - $10.34 $3.39 Million - $4.17 Million	-403,141 Reduced 5.8%	6,544,806 $59.3 Million
Q1 2022 May 13, 2022	BUY	$8.33 - $12.96 $5.4 Million - $8.4 Million	648,124 Added 10.29%	6,947,947 $66.4 Million
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $3.29 Million - $4.9 Million	443,268 Added 7.57%	6,299,823 $69.6 Million
Q3 2021 Nov 12, 2021	BUY	$6.77 - $14.41 $3.91 Million - $8.32 Million	577,586 Added 10.94%	5,856,555 $43.3 Million
Q2 2021 Aug 13, 2021	BUY	$14.52 - $22.46 $76.7 Million - $119 Million	5,278,969 New	5,278,969 $76.7 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Theravance Biopharma, Inc. Transaction History